Key Financial Inc’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-100
| Closed | -$1.45K | – | 1383 |
|
|
2026
Q1 | $1.45K | Hold |
100
| – | – | ﹤0.01% | 1211 |
|
|
2025
Q4 | $1.42K | Hold |
100
| – | – | ﹤0.01% | 1220 |
|
|
2025
Q3 | $771 | Hold |
100
| – | – | ﹤0.01% | 1297 |
|
|
2025
Q2 | $573 | Hold |
100
| – | – | ﹤0.01% | 1313 |
|
|
2025
Q1 | $816 | Hold |
100
| – | – | ﹤0.01% | 1246 |
|
|
2024
Q4 | $942 | Hold |
100
| – | – | ﹤0.01% | 1236 |
|
|
2024
Q3 | $1.07K | Hold |
100
| – | – | ﹤0.01% | 1187 |
|
|
2024
Q2 | $992 | Hold |
100
| – | – | ﹤0.01% | 1186 |
|
|
2024
Q1 | $1.18K | Hold |
100
| – | – | ﹤0.01% | 1163 |
|
|
2023
Q4 | $1.42K | Hold |
100
| – | – | ﹤0.01% | 1140 |
|
|
2023
Q3 | $1.22K | Hold |
100
| – | – | ﹤0.01% | 1167 |
|
|
2023
Q2 | $1.26K | Hold |
100
| – | – | ﹤0.01% | 1213 |
|
|
2023
Q1 | $1.11K | Hold |
100
| – | – | ﹤0.01% | 1021 |
|
|
2022
Q4 | $1.04K | Hold |
100
| – | – | ﹤0.01% | 1029 |
|
|
2022
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 1029 |
|
|
2022
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 1016 |
|
|
2022
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 1002 |
|
|
2021
Q4 | $1K | Hold |
100
| – | – | ﹤0.01% | 888 |
|
|
2021
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 862 |
|
|
2021
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 815 |
|
|
2021
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 725 |
|
|
2020
Q4 | $2K | Buy |
+100
| New | +$2.04K | ﹤0.01% | 641 |
|
|
2020
Q2 | – | Sell |
-100
| Closed | -$1K | – | 287 |
|
|
2020
Q1 | $1K | Buy |
+100
| New | +$951 | ﹤0.01% | 640 |
|
Other funds holding FOLD
Key Financial Inc's FOLD Position: Q2 2026 in Review
Key Financial Inc sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 100 shares — an estimated $1.45K sold.
Key Financial Inc first reported a position in FOLD in Q1 2020 and held it in 23 quarters. The position peaked at $2K in Q4 2020. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.
- Key Financial Inc reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
- Key Financial Inc sold 100 Amicus Therapeutics shares in Q2 2026, an estimated $1.45K.
- Key Financial Inc first reported a position in Amicus Therapeutics in Q1 2020 and held it in 23 quarters.
- Key Financial Inc's Amicus Therapeutics position peaked at $2K in Q4 2020.
- 1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.
Based on Key Financial Inc's 13F filing for Q2 2026, filed 24 Jul 2026.